Matthew L. Sherman
2019 - Deciphera Pharmaceuticals
In 2019, Matthew L. Sherman earned a total compensation of $5.1M as EVP, Chief Medical Officer at Deciphera Pharmaceuticals.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Non-Equity Incentive Plan | $84,593 |
| Option Awards | $3,458,715 |
| Salary | $125,000 |
| Stock Awards | $1,205,050 |
| Other | $115,164 |
| Total | $5,138,522 |
Sherman received $3.5M in option awards, accounting for 67% of the total pay in 2019.
Sherman also received $150K in bonus, $84.6K in non-equity incentive plan, $125K in salary, $1.2M in stock awards and $115.2K in other compensation.
Rankings
In 2019, Matthew L. Sherman's compensation ranked 2,122nd out of 13,971 executives tracked by ExecPay. In other words, Sherman earned more than 84.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,122 out of 13,971 | 85th |
Division Manufacturing | 767 out of 5,695 | 87th |
Major group Chemicals And Allied Products | 238 out of 2,194 | 89th |
Industry group Drugs | 193 out of 1,880 | 90th |
Industry Pharmaceutical Preparations | 140 out of 1,392 | 90th |
Source: SEC filing on April 24, 2020.
Sherman's colleagues
We found four more compensation records of executives who worked with Matthew L. Sherman at Deciphera Pharmaceuticals in 2019.